Literature DB >> 1418367

The SKT neuropsychological test battery.

J E Overall1, R Schaltenbrand.   

Abstract

The SKT is a brief neuropsychological test battery that includes nine performance subtests that define two independent factors of memory and attention deficit. It requires no more than 15 minutes to administer and has five parallel forms. Developed in Germany, it has been used successfully to document improved performance of patients in trials of antidementia drugs in that country. This article addresses factor structure and scoring, dementia profile classification, reliability, and validity data. The SKT appears to hold promise for efficient assessment of objective performance changes to supplement clinical evaluations of therapeutic efficacy of new drugs for treatment of senile dementia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1418367     DOI: 10.1177/002383099200500407

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  8 in total

1.  Introducing CARESSER: A framework for in situ learning robot social assistance from expert knowledge and demonstrations.

Authors:  Antonio Andriella; Carme Torras; Carla Abdelnour; Guillem Alenyà
Journal:  User Model User-adapt Interact       Date:  2022-03-12       Impact factor: 4.412

2.  Reductions in qEEG slowing over 1 year and after treatment with Cerebrolysin in patients with moderate-severe traumatic brain injury.

Authors:  X Antón Alvarez; Carolina Sampedro; Jesús Figueroa; Iván Tellado; Andrés González; Manuel García-Fantini; Ramón Cacabelos; Dafin Muresanu; Herbert Moessler
Journal:  J Neural Transm (Vienna)       Date:  2008-02-14       Impact factor: 3.575

Review 3.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014

4.  Validation of Chinese Version of SKT (Syndrom Kurztest): A Short Cognitive Performance Test for the Assessment of Memory and Attention.

Authors:  Yao Lu; Jingchao Hu; Mark Stemmler; Qihao Guo
Journal:  Diagnostics (Basel)       Date:  2021-12-01

Review 5.  Donepezil for dementia due to Alzheimer's disease.

Authors:  Jacqueline S Birks; Richard J Harvey
Journal:  Cochrane Database Syst Rev       Date:  2018-06-18

6.  Variability in the validity and reliability of outcome measures identified in a systematic review to assess treatment efficacy of cognitive enhancers for Alzheimer's Dementia.

Authors:  Charlene Soobiah; Mina Tadrous; Sandra Knowles; Erik Blondal; Huda M Ashoor; Marco Ghassemi; Paul A Khan; Joanne Ho; Andrea C Tricco; Sharon E Straus
Journal:  PLoS One       Date:  2019-04-18       Impact factor: 3.240

7.  [Emotional status, cognitive performance and quality of life in HIV-infected patients. Results of an exploratory study].

Authors:  D Baumschlager; A Haas-Krammer; H-B Rothenhäusler
Journal:  Nervenarzt       Date:  2011-07       Impact factor: 1.214

8.  Preoperational chronic pain impairs the attention ability before surgery and recovery of attention and memory abilities after surgery in non-elderly patients.

Authors:  Huahua Gu; Xianyu Deng; Yizheng Lv; Qian Chen; Weifeng Yu
Journal:  J Pain Res       Date:  2018-12-27       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.